₹99.2 4.7 5.0%
Last Trade - 20/04/21
| Market Cap | £10.4m |
| Enterprise Value | £12.6m |
| Revenue | £3.28m |
| Position in Universe | th / 3108 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Mar | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018E | 2019E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 34.4 | 118 | 129.7 | 268.2 | 344.2 | +77.8% | ||||
| -56.3 | +728.1 | |||||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Arvee Laboratories (India) Limited is an India-based company that provides specialty chemical products. The Company is primarily engaged in manufacturing of Polymer Modifiers, Contrast Media Intermediates and Drug Intermediates. The Company’s Polymer Modifiers includes 5-Sulfoisophthalic Acid Mono Sodium Salt, Dimethyl 5-Sodiosulfoisophthalate and 5-Sulfoisophthalic Acid Mono Lithium Salt. Its Contrast Media Intermediates includes 5-Nitroisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, Monomethyl 5-Nitroisophthalate, 3,5-Diamino Benzoic Acid, Dimethyl 5-Aminoisophthalate and 3,5-Dinitrobenzoic Acid. Its Drug Intermediates includes 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine and 2-Chloro-5-Nitrobenzoic Acid.
| Last Annual | March 31st, 2017 |
| Last Interim | September 30th, 2017 |
| Incorporated | January 27, 2012 |
| Public Since | February 22, 2018 |
| No. of Shareholders: | n/a |
| No. of Employees: | n/a |
| Sector | Basic Materials |
| Industry | Chemicals |
| Index | |
| Exchange | National Stock Exchange of India |
| Shares in Issue | 11,020,000 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | , AHMEDABAD, 380058, India |
| Web | http://arveelabs.com/ |
| Phone | +91 2717 430479 |
| Contact | () |
| Auditors | JAIMIN DELIWALA & CO. |
As of 20/04/21, shares in Arvee Laboratories (India) are trading at ₹99.2, giving the company a market capitalisation of £10.4m. This share price information is delayed by 15 minutes.
Shares in Arvee Laboratories (India) are currently trading at ₹99.2 and the price has moved by 0.322k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Arvee Laboratories (India) price has moved by 0.166k% over the past year.
There are no analysts currently covering Arvee Laboratories (India).
Arvee Laboratories (India) is scheduled to issue upcoming financial results on the following dates:
Arvee Laboratories (India) does not currently pay a dividend.
Arvee Laboratories (India) does not currently pay a dividend.
Arvee Laboratories (India) does not currently pay a dividend.
To buy shares in Arvee Laboratories (India) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Arvee Laboratories (India) are currently trading at ₹99.2, giving the company a market capitalisation of £10.4m.
Here are the trading details for Arvee Laboratories (India):
We were not able to load our ranking data for Arvee Laboratories (India)
We were not able to load any forecast data for Arvee Laboratories (India).
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Arvee Laboratories (India). Over the past six months, the relative strength of its shares against the market has been 97.78%. At the current price of ₹99.2, shares in Arvee Laboratories (India) are trading at 0.168k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Arvee Laboratories (India) PE ratio based on its reported earnings over the past 12 months is 70.45. The shares are currently trading at ₹99.2.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Arvee Laboratories (India)'s management team is headed by:
Here are the top five shareholders of Arvee Laboratories (India) based on the size of their shareholding:
